Moreover, KIF4A overexpression reversed the inhibitory effect of WZ-3146 on glioma cell activity, suggesting that WZ-3146 can inhibit glioma progression by inhibiting KIF4A expression. This evidence concerns the gene KIF4A and central nervous system cancer.